title: Who should receive antiendotoxin monoclonal antibody therapy?
authors.forename: T C
authors.initials: TC
authors.lastname: Hardin
authors.forename: J T
authors.initials: JT
authors.lastname: DiPiro
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D016527:Drug Costs; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007075:Immunoglobulin M; D010606:Pharmacy and Therapeutics Committee
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C071470:edobacomab; C068069:nebacumab